First Citizens Bank & Trust’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-2,945
Closed -$341K – 408
2018
Q3
$341K Buy
2,945
+780
+36% +$88K 0.04% 291
2018
Q2
$273K Buy
+2,165
New +$264K 0.03% 364

Other funds holding CLB

First Citizens Bank & Trust's CLB Position: Q4 2018 in Review

First Citizens Bank & Trust sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 2,945 shares — an estimated $341K sold.

First Citizens Bank & Trust first reported a position in CLB in Q2 2018 and held it in 2 quarters. The position peaked at $341K in Q3 2018. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

  • First Citizens Bank & Trust reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
  • First Citizens Bank & Trust sold 2,945 Core Laboratories shares in Q4 2018, an estimated $341K.
  • First Citizens Bank & Trust first reported a position in Core Laboratories in Q2 2018 and held it in 2 quarters.
  • First Citizens Bank & Trust's Core Laboratories position peaked at $341K in Q3 2018.
  • 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on First Citizens Bank & Trust's 13F filing for Q4 2018, filed 15 Jan 2019.